SCHEMBL30740738

SCHEMBL30740738

Cc1ccc(OCc2cccc(CC3CCCCN3C(=O)OC(C)(C)C)n2)c(C#N)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.37
▸ MAPT P10636 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ F2RL3 Q96RI0 2/20 0.37
▸ ALOX5AP P20292 1/20 0.37
▸ FEN1 P39748 1/20 0.37
▸ UCHL1 P09936 1/20 0.37
▸ CHEK2 O96017 1/20 0.37
▸ GPR119 Q8TDV5 4/20 0.36
▸ METTL3 Q86U44 1/20 0.36
▸ GRM5 P41594 1/20 0.36
▸ KDM1A O60341 1/20 0.36
▸ HCRTR1 O43613 1/20 0.36
▸ HCRTR2 O43614 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ PDE8B O95263 1/20 0.35
▸ MET P08581 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30740841 0.87 L3MBTL1 (0.38) PRMT5L3MBTL1NPSR1MAPTLMNA
SCHEMBL30740694 0.85 HCRTR2 (0.41) PRMT5L3MBTL1NPSR1MAPTLMNA
SCHEMBL29826499 0.85 GPR119 (0.46) LMNAGPR119
SCHEMBL30740732 0.80 MRGPRX4 (0.45) PRMT5LMNAALOX5APFEN1CHEK2
SCHEMBL30740781 0.78 KDM1A (0.44) PRMT5NPSR1MAPTLMNAALOX5AP
SCHEMBL29826235 0.71 GPR119 (0.45) LMNAGPR119
SCHEMBL29826374 0.70 GPR119 (0.43) MAPTLMNAGPR119
SCHEMBL26802554 0.69 GPR119 (0.47) F2RL3ALOX5APFEN1GPR119
SCHEMBL26802291 0.69 GPR119 (0.47) F2RL3ALOX5APFEN1GPR119
SCHEMBL2512853 0.69 METTL3 (0.45) PRMT5L3MBTL1NPSR1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117043154-A GPCR receptor agonists, pharmaceutical compositions comprising same, and methods of use thereof 卡莫特医疗有限公司 2023-11-10 — — CN disclosed
Send feedback